Larry Mathis Financial Planning’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$530K Sell
8,492
-405
-5% -$25.6K 0.45% 46
2026
Q2
$513K Buy
8,897
+702
+9% +$40.3K 0.39% 67
2026
Q1
$497K Buy
8,195
+273
+3% +$15.9K 0.45% 52
2025
Q4
$427K Buy
+7,922
New +$381K 0.38% 82

Other funds holding BMY

Larry Mathis Financial Planning's BMY Position: Q3 2026 in Review

Larry Mathis Financial Planning reduced its Bristol-Myers Squibb (BMY) stake by 4.6% in Q3 2026, selling an estimated $25.6K and leaving 8,492 shares worth $530K. The position accounts for 0.45% of the portfolio, ranked #46.

Larry Mathis Financial Planning first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Larry Mathis Financial Planning held 8,492 shares of Bristol-Myers Squibb worth $530K as of Q3 2026.
  • Larry Mathis Financial Planning sold 405 Bristol-Myers Squibb shares in Q3 2026, an estimated $25.6K.
  • Bristol-Myers Squibb made up 0.45% of Larry Mathis Financial Planning's portfolio in Q3 2026, its #46 holding.
  • Larry Mathis Financial Planning first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Larry Mathis Financial Planning's 13F filing for Q3 2026, filed 26 Oct 2026.